Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The lung in inflammatory bowel disease

P Camus1, F Piard, T Ashcroft

  • 1Services de Pneumologie, University Hospital and Medical School, Université de Bourgogne, Dijon, France.

Medicine
|May 1, 1993
PubMed
Summary

Patients with inflammatory bowel disease (IBD) can develop various lung complications, including airway inflammation and interstitial lung disease. Many of these steroid-sensitive respiratory issues require prompt diagnosis and treatment for effective management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review.

Journal of public health (Oxford, England)·2025
Same author

New Limit for Neutrinoless Double-Beta Decay of ^{100}Mo from the CUPID-Mo Experiment.

Physical review letters·2021
Same author

First Germanium-Based Constraints on Sub-MeV Dark Matter with the EDELWEISS Experiment.

Physical review letters·2020
Same author

Spectrum and Energy Levels of Neutral Thulium.

Journal of research of the National Bureau of Standards. Section A, Physics and chemistry·2020
Same author

Development of <math> </math> -containing scintillating bolometers for a high-sensitivity neutrinoless double-beta decay search.

The European physical journal. C, Particles and fields·2020
Same author

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. 2017 update. Full-length update].

Revue des maladies respiratoires·2017

Area of Science:

  • Pulmonology
  • Gastroenterology
  • Rheumatology

Background:

  • Respiratory involvement in inflammatory bowel disease (IBD) is a recognized extraintestinal manifestation.
  • Distinguishing IBD-related lung disease from drug-induced lung injury (e.g., sulfasalazine, mesalamine) is crucial but challenging.
  • A significant delay in diagnosis and treatment of bronchopulmonary complications in IBD patients has been observed.

Purpose of the Study:

  • To characterize the spectrum of bronchopulmonary complications in patients with IBD.
  • To analyze the temporal relationship between IBD onset and respiratory manifestations.
  • To evaluate the efficacy of corticosteroid therapy in managing these lung conditions.

Main Methods:

  • Retrospective analysis of data from an ongoing Registry of 33 IBD patients with respiratory involvement.

Related Experiment Videos

  • Classification of pulmonary manifestations into airway inflammation, interstitial lung disease, and miscellaneous forms.
  • Assessment of treatment responses to inhaled, oral, and intravenous corticosteroids, and bronchial lavages.

    • Main Results:

    • Respiratory involvement occurred after IBD onset in most cases (28/33), with some cases presenting post-colectomy.
    • Observed patterns included airway inflammation (subglottic stenosis, chronic bronchitis, bronchiectasis) and interstitial lung disease (bronchiolitis obliterans organizing pneumonia).
    • Corticosteroids were highly effective in most cases, with varying benefits depending on the specific lung involvement and route of administration.

    Conclusions:

    • Inflammatory bowel disease patients are susceptible to diverse pulmonary inflammatory complications.
    • Prompt diagnosis and management, particularly with corticosteroids, are essential for improving outcomes in IBD-associated lung disease.
    • The effectiveness of steroids varies, with intravenous administration often necessary for severe or life-threatening conditions.